Xcout Intel
Ena Respiratory
ENA Respiratory is a clinical-stage pharmaceutical company headquartered in Melbourne, Australia, developing antiviral host defense enhancers to prevent respiratory infections.
Subscribe to see Ena Respiratory’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ena Respiratory at a glance
Ena Respiratory is a healthcare company headquartered in Australia. Its most recent funding round, Series B, raised $22.4M in October 2025. Xcout tracks 8 named people at Ena Respiratory, including Christophe Demaison (CEO).
Ena Respiratory leadership
- Christophe DemaisonCEO
- Rohina BatraChief Financial Officer
- Courtney CrimChief Medical Officer
- Francesca MercuriDirector of Biology
- Grant MclachlanDirector, CMC Program Management
- George H KlingerClinical Operations, US
2 more named people on record for Ena Respiratory, with roles, board committees and tenure — see the full roster →
Ena Respiratory funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $22.4M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Ena Respiratory competitors
A few of Ena Respiratory's closest competitors — see the full list of competitors and alternatives →
Ausperbio is a clinical-stage biopharmaceutical company dedicated to transforming hepatitis B virus (HBV) treatment for a cure and advancing oligonucleotide therapeutics.
Airway Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel biologic therapies for respiratory and other diseases. The company is headquartered in Atlanta, Georgia.
Enzymatica develops health solutions and barrier technology products, such as the ColdZyme mouth spray, designed to support the body's defense against viruses and micro-organisms. The company serves consumers looking to prevent or alleviate common cold symptoms and respiratory infections.
Island Pharmaceuticals Ltd is an Australian antiviral drug development company based in Melbourne, Australia, focused on addressing infectious diseases.
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Get Ena Respiratory's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ena Respiratory? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ena Respiratory in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access